You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAS and BRAF wild type

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • mFOLFOX6 + Cetuximab
  • mFOLFOX 6
  • Shanghai, China
    Zhongshan hosptial, Fudan University
Jul 14, 2023

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

Recruiting
  • Unresectable Colon Cancer Peritoneal Metastases
  • PMMR/Ras/BRAF Wild-type
  • Serplulimab Combined With FOLFIRI and Bevacizumab
  • Huzhou, Zhejiang, China
    Changxing County People's Hospital
Feb 14, 2023

Metastatic Colorectal Cancer Trial in Beijing, Tianjin (CMAB009, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +1 more
Oct 18, 2022

Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus capecitabine
  • Beijing, China
    National Center/Cancer Hospital, China Academy of Medical Scienc
Aug 17, 2022

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,

Completed
  • Colorectal Cancer
  • +12 more
  • Anlotinib Hydrochloride
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 12, 2022

Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation Trial in Italy (Bevacizumab, Cetuximab, 5-FU)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Coppito, L'Aquila, Italy
  • +3 more
Sep 10, 2021

Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

Recruiting
  • Colorectal Cancer
  • Pisa, PI, Italy
    U.O. Oncologia 2 Universitaria
Aug 3, 2022

Colorectal Tumors, Colorectal Carcinoma, Colorectal Cancer Metastatic Trial in Spain (Panitumumab, Irinotecan, Folinic acid)

Completed
  • Colorectal Neoplasms
  • +3 more
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +11 more
Jun 18, 2021

Colo-rectal Cancer, Capecitabine, Cetuximab Trial in Chengdu (mCapOX plus cetuximab, mFOLFOX6 plus cetuximab)

Recruiting
  • Colo-rectal Cancer
  • +2 more
  • mCapOX plus cetuximab
  • mFOLFOX6 plus cetuximab
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Sep 1, 2021

Colo-rectal Cancer Trial in Beijing (Experimental: mXELOX plus cetuximab, Active Comparator: FOLFOX plus cetuximab)

Recruiting
  • Colo-rectal Cancer
  • Experimental: mXELOX plus cetuximab
  • Active Comparator: FOLFOX plus cetuximab
  • Beijing, China
    Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Sep 29, 2021

Metastatic Colorectal Cancer Trial in Italy (Cetuximab, Avelumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Ancona, Italy
  • +23 more
Oct 25, 2022

Colorectal Cancer, Liver Metastases Trial (Cetuximab, Bevacizumab, mFOLFOX/FOLFIRI ( Standard Chemotherapy))

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • (no location specified)
Aug 23, 2020

Colorectal Tumors Trial in Worldwide (Tepotinib, Cetuximab)

Active, not recruiting
  • Colorectal Neoplasms
  • Phoenix, Arizona
  • +66 more
Nov 19, 2021

Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Mar 23, 2023

Metastatic Colorectal Cancer Trial (C225+CPT-11)

Unknown status
  • Metastatic Colorectal Cancer
  • (no location specified)
Jan 15, 2020

Colorectal Cancer Stage IV Trial in Napoli (Panitumumab)

Completed
  • Colorectal Cancer Stage IV
  • Napoli, Italy
    Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pasc
Apr 6, 2022

Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023

Vectibix With Chemotherapy for Metastatic Colorectal Cancer

Completed
Has Results
  • Wild-type RAS Metastatic Colorectal Cancer
  • Panitumumab + Chemotherapy
  • (no location specified)
Nov 4, 2022

Disease or R Group Histiocytoses Trial in Paris (Cobimetinib, Placebo oral tablet)

Active, not recruiting
  • Disease or R Group Histiocytoses
  • Paris, France
    Service de Médecine interne - La Pitié Salpêtrière
Mar 21, 2022

Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023

New Prognostic Score for Adult RAS Wild-type mCRC Treated With

Active, not recruiting
  • Metastatic Colorectal Cancer
  • RAS Wild-type
  • Freiburg, Baden-Württemberg, Germany
    Praxis für interdisziplinäre Onkologie & Hämatologie
Jul 29, 2022

Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

Completed
  • Metastatic Colorectal Cancer
  • RAS Wild Type
  • Napoli, Italy
    Università della Campania Luigi Vanvitelli
May 4, 2022